Southern Company Operating Cash Flow decreased by 1.9% to $1.23B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.9%, from $1.25B to $1.23B. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $1.66B | $2.18B | $1.09B | $1.59B | $1.99B | $1.44B | $1.25B | $1.23B |
| QoQ Change | — | +31.0% | -50.0% | +46.3% | +24.8% | -27.6% | -13.1% | -1.9% |
| YoY Change | — | — | — | — | +19.6% | -33.9% | — | -1.9% |